# Mylan Pharmaceuticals Inc. – FDA Inspection, Nov 9, 2017

Source: https://www.keypedia.com/records/fda_inspections/mylan-pharmaceuticals-inc/2c4dead4-ce51-48f0-992f-d44ab3448462
Source feed: FDA_Inspections

> FDA inspection 1031174 of Mylan Pharmaceuticals Inc., November 09, 2017. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1031174
- Company Name: Mylan Pharmaceuticals Inc.
- Inspection Date: 2017-11-09
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: New Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: San Francisco District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 1132054 - 2020-09-22
- FDA Inspection 990174 - 2016-10-14
- [FDA Inspection 937344 - 2015-07-17](https://www.keypedia.com/records/fda_inspections/mylan-pharmaceuticals-inc/252a64f1-2dd4-4f8b-954b-5c761352260d)
- FDA Inspection 894744 - 2014-09-04
- FDA Inspection 799168 - 2012-09-27

## Related Officers

- [Ashar P. Parikh](https://www.keypedia.com/people/ashar-p-parikh/f5430c51-31c7-44bb-90f7-1ec8ae581343)
- [FDA Associated Person](https://www.keypedia.com/people/kristin-m-abaonza/cf909da8-837d-4dfe-9ccc-288b24d7bba3)
- Issuing Officer

Company: https://www.keypedia.com/companies/mylan-pharmaceuticals-inc/544e75ba-feb1-4947-b3da-4883556581f1

Office: https://www.keypedia.com/offices/san-francisco-district-office/6f838e9c-aae1-4665-9c46-a51d43be02df